BRITTANY VAN KAMPEN: Open Payments
NPI 1154931350 · HIGHLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,534 in 129 payments from 17 companies in 2025. Trend: 2023 $1,878 · 2024 $2,140 · 2025 $3,534
Food & beverage: $3,500Education: $34
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 24 | $865 |
| AstraZeneca Pharmaceuticals LP | 15 | $556 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $400 |
| Novartis Pharmaceuticals Corporation | 13 | $298 |
| ARS Pharmaceuticals Operations, Inc. | 13 | $266 |
| GlaxoSmithKline, LLC. | 9 | $209 |
| Regeneron Healthcare Solutions, Inc. | 8 | $206 |
| Amgen Inc. | 9 | $164 |
| Ionis Pharmaceuticals, Inc. | 5 | $131 |
| CSL Behring | 4 | $116 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, CUVITRU, TAKHZYRO, Rhapsido, NUCALA, DAWNZERA.
Industry payments across IL — which companies pay providers there.
